FS120 Phase 1/1b Study in Patients With Advanced Malignancies

NCT04648202 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

82

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Cancer
Metastatic Cancer

Interventions

DRUG: FS120

Sponsor

invoX Pharma Limited

Collaborators

[object Object]